The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The IAS–USA designates this live activity for a maximum of 17.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC Points
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 17.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Since 2006, the IAS–USA has held Accreditation with Commendation. As such, the IAS–USA belongs to an elite group of organizations in the United States that have been awarded this prestigious status, which, in the words of the ACCME, is “reserved for programs that are truly exceptional.” CME credits can be claimed for plenary lectures, symposia, opening session lectures, and special sessions. CME credits cannot be claimed for oral abstract sessions, themed discussion sessions, or poster sessions.
How do I claim ABIM MOC points?
The International Antiviral Society–USA offers American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) points.
- ABIM MOC points are intended for internal medicine physicians, in the United States, who are maintaining their ABIM Board Certification.
- ABIM MOC points will only be awarded after the successful completion of the evaluation component demonstrating knowledge gained at all meetings through a series of multiple choice questions.
- Data will be uploaded to PARS 1 day after the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) post-test has closed.
- Once the data is in the PARS system, it will be transferred to ABIM within 72 hours
- Once ABIM receives the information, they will upload it to the member account and send the doctor an email, informing them that ABIM MOC points have been added to their account.
After participating in CROI 2018, participants will be able to:
- Describe current basic science research on the pathogenesis of HIV and on advances toward a cure
- List the most recent findings from clinical trials in the field of HIV and the implications of these data for state-of-the-art treatment strategies
- Describe current epidemiologic data on the prevalence of HIV infection, transmission, treatment, and linkage to and retention in care in populations worldwide; the implications of these data for public-health program planning; and current advances in biobehavioral prevention
Statement of Need
Since HIV was identified, the scientific response to the global pandemic has been a coordinated effort among basic researchers, clinical investigators, health care providers, epidemiologists, and community leaders to move information and potential treatment options from research to clinical trials and out to affected communities as quickly as possible. CROI was founded in 1993 by researchers working in the field of HIV/AIDS and its complications, as a science-focused forum for exchanging current research findings among their international peers. CROI continues to focus on scientific exchange, providing an environment in which basic science researchers, translational researchers, clinical investigators, epidemiologists, and public health experts meet to present and discuss the latest research on different facets of HIV and its complications.
Disclosure of Financial Relationships
It is the policy of the IAS–USA to ensure balance, independence, objectivity, and scientific rigor in all its educational activities. All faculty members (speakers, presenters, etc) participating in IAS–USA-sponsored activities are required to disclose to the program audience any financial interests within the past 12 months that could be perceived to influence, or give the appearance of potentially influencing, the written or oral presentation. (The ACCME defines a financial interest as an interest in any amount.) The information is intended to make the IAS–USA audience aware of speaker and contributor interests and commitments with commercial companies or other entities, enabling the audience members to form their own judgments about such associations.
Each author or contributor is required to complete this financial disclosure declaration. In accordance with IAS–USA policy, the IAS–USA will identify and resolve ahead of time any possible conflicts of interest that may influence CME activities with regard to exposition or conclusion. Disclosure information will be included with the Program and Abstracts eBook on the web.
Drug and Product Disclamer
This activity may contain information about the investigational uses of drugs or products that are not approved by the US Food and Drug Administration. Please consult full prescribing information before using any medication or product mentioned in this activity.